Breaking News

Close

Eyepoint Pharmaceuticals Inc (EYPT)

	Symbol	Exchange	Currency
	EYPT	NASDAQ	USD	Real-time
	PV3B	Frankfurt	EUR	Delayed

Add to/Remove from Watchlist Add to Watchlist

16.160 -0.310 -1.88%

16:00:04 - Closed. Currency in USD ( Disclaimer )

After Hours

16.640

+0.480

+2.970%

17:39:21 - Real-time Data

Type: Equity

Market: United States

Volume: 732,212
Bid/Ask: 14.980 / 16.930
Day's Range: 15.510 - 16.230

NASDAQ:EYPT Financials

A brief overview of the NASDAQ:EYPT financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of pSivida over time.

EyePoint Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 15.2 million compared to USD 10.01 million a year ago. Net loss was USD 12.61 million compared to USD 18.42 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.49 a year ago.For the nine months, revenue was USD 31.99 million compared to USD 30.87 million a year ago. Net loss was USD 56.7 million compared to USD 58.8 million a year ago. Basic loss per share from continuing operations was USD 1.5 compared to USD 1.58 a year ago.

Annual Quarterly

InvestingPro

Advanced Financial Summary

TTM = Trailing Twelve Months

MRQ = Most Recent Quarter

EYPT Income Statement

Gross margin TTM -49.93%

Operating margin TTM -160.52%

Net Profit margin TTM -153.84%

Return on Investment TTM -30.65%

Total Revenue Net Income

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue	14.03	15.2	9.1	7.68
Gross Profit	-5.49	-3.07	-8.13	-6.28
Operating Income	-15.15	-14.4	-22.76	-21.55
Net Income	-14.1	-12.61	-22.92	-21.16

EYPT Balance Sheet

Quick Ratio MRQ 5.25

Current Ratio MRQ 5.45

LT Debt to Equity MRQ -

Total Debt to Equity MRQ 2.05%

Total Assets Total Liabilities

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets	355.18	160.04	175.66	154.59
Total Liabilities	88.86	101.42	118.39	76.2
Total Equity	266.32	58.62	57.26	78.39

EYPT Cash Flow Statement

Cash Flow/Share TTM 0.04

Revenue/Share TTM 0.98

Operating Cash Flow -36.53%

Cash Net Change in Cash

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Period Length:	0 Months	0 Months	0 Months	0 Months
Cash From Operating Activities	-23.11	-15.2	57.02	-16.84
Cash From Investing Activities	-47.15	-1.72	13.47	32.09
Cash From Financing Activities	218.48	10.36	-36.66	-5.12
Net Change in Cash	148.23	-6.56	33.83	10.13

* In Millions of USD (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

EYPT Comments

Write your thoughts about Eyepoint Pharmaceuticals Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

John Johnson Aug 22, 2023 1:28PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

20?

0 0

matanel liberman Jul 28, 2023 2:51PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

14 soon

2 0

matanel liberman Jul 08, 2023 6:28AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

10 soon

2 0

Joe Jordan Apr 23, 2023 1:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

EyePoint Pharmaceuticals was initiated with an Outperform rating and $33 per share price target at Baird on Friday, pushing its share price significantly higher ($9)

1 0

Tamara AMAL Apr 23, 2023 1:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

what's going on with Egypt,???

0 0

Tamara AMAL Apr 23, 2023 1:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

what's going on, dipping?

0 0

Joe Jordan Nov 18, 2021 6:12AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

EyePoint Pharma secures $100M capital raise via equity offering

1 0

Joe Jordan Nov 16, 2021 1:57AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Yesterday value moved from 14.0 to 21.5 and during the day moved back to 14.3 dollars

0 0

Joe Jordan Nov 16, 2021 1:54AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Shares of EyePoint Pharmaceuticals Inc. reached a new 52-week intraday high after the company reported positive data from its Phase 1 DAVIO study of EYP-1901 in Wet AMD and announced plans to move forward to additional Phase 2 clinical trials in 2022.

0 0

Joe Jordan Feb 13, 2021 6:45AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Any possible target price?

0 0

Joe Jordan Jan 04, 2021 5:07PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Do you reckon can come back to 20 USD?

0 0

Marcos Remy Jan 04, 2021 4:12PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

What h?

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="215158420">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="215158420" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="215158420" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="215158420">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="248306766">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="248306766" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="248306766" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="248306766">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,129.8	+44.0	+0.12%
	US 500	5,088.6	+40.2	+0.80%
	Dow Jones	38,085.80	-375.12	-0.98%
	S&P 500	5,048.42	-23.21	-0.46%
	Nasdaq	15,611.76	-100.99	-0.64%
	S&P 500 VIX	15.37	-0.60	-3.76%
	Dollar Index	105.435	-0.265	-0.25%

	Crude Oil WTI	83.79	+0.22	+0.26%
	Brent Oil	89.28	+0.10	+0.11%
	Natural Gas	1.985	+0.005	+0.25%
	Gold	2,343.55	+1.05	+0.04%
	Silver	27.425	+0.072	+0.26%
	Copper	4.5418	-0.0027	-0.06%
	US Soybeans	1,162.25	-2.75	-0.24%

	U.S. 10Y	4.714	+0.006	+0.13%
	U.S. 30Y	4.813	+-0.007	+-0.14%
	U.S. 5Y	4.719	+0.002	+0.04%
	U.S. 3M	5.416	+0.012	+0.23%
	US 10Y T-Note	107.34	-0.02	-0.01%
	Euro Bund	129.70	-0.40	-0.31%
	10-2 Yield Spread	-28.51	+4.78	+-14.36%

	Apple	169.89	+0.87	+0.51%
	Alphabet A	156.00	-3.13	-1.97%
	Tesla	170.18	+8.05	+4.97%
	Amazon.com	173.67	-2.92	-1.65%
	Netflix	564.80	+9.68	+1.74%
	Meta Platforms	441.38	-52.12	-10.56%
	Bank of America	37.91	-0.41	-1.07%

Recent Quotes

	Name	Price	Chg.	Chg. %
	EYPT	16.160	-0.310	-1.88%

	Name	Last	Chg. %	Vol.
	TSLA	170.18	+4.97%	123.18M
	META	441.38	-10.56%	81.83M
	AAPL	169.89	+0.51%	47.93M
	AMZN	173.67	-1.65%	43.43M
	NVDA	826.32	+3.71%	40.15M
	MSFT	399.04	-2.45%	34.49M
	BRKa	611,740	-0.27%	12.48K

	Name	Last	Chg. %	Vol.
	NEM	43.41	+12.46%	36.00M
	TYL	458.45	+9.42%	501.35K
	CARR	59.81	+9.20%	9.94M
	TER	108.91	+8.15%	7.83M
	CMG	3,116.02	+6.47%	641.35K
	URI	690.92	+5.45%	1.02M
	ZBRA	292.53	+5.40%	658.63K

	Name	Last	Chg. %	Vol.
	META	441.38	-10.56%	81.83M
	TXT	84.92	-9.67%	5.13M
	BMY	44.68	-8.56%	44.90M
	IBM	169.30	-8.04%	16.60M
	LUV	27.25	-6.98%	36.89M
	CAT	338.24	-6.95%	6.37M
	CMCSA	37.87	-5.82%	36.78M